The Lancet Respiratory Medicine in conversation with

Solange Peters, Lizza Hendricks, and Martin Reck join Jonathan Blott to discuss The Lancet Respiratory Medicine Series on therapeutics in lung cancer, published to coincide with the Series launch at ERS 2026. The Series reviews developments in the treatment of non-small-cell lung cancer, from emerging approaches in early-stage disease to targeted therapies for advanced disease. The authors discuss the evidence supporting existing treatment strategies, areas of uncertainty in clinical practice, new and emerging biomarkers, and priorities for further research.

Click here to read the full series:

https://doi.org/10.1016/ S2213-2600(26)00221-3

https://doi.org/10.1016/ S2213-2600(26)00253-5

Andrew Bush, Heather Zar, Fernando de Benedictis talk about their recent personal view piece where they summarise and discuss the 50-year journey and evolution of inhaled corticosteroids (ICS) in asthma treatment.

Click here to read the full articles:

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00082-2/abstract

Anne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability. 

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00051-2/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Anne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis.

Click here to read the full article, Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a randomised sham-controlled trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00005-6/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Marion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury for the prediction of functional outcome in patients after cardiac arrest using assays that can be analysed on clinically available equipment.

Click here to read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00363-7/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv